Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial (Q44166493)

30 November 2017

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial (English)

1 reference

30 November 2017

prevention of HIV/AIDS

0 references

1 reference

0 references

D W Fitzgerald

1

1 reference

30 November 2017

M Desvarieux

2

1 reference

30 November 2017

P Severe

3

1 reference

30 November 2017

P Joseph

4

1 reference

30 November 2017

W D Johnson

5

1 reference

30 November 2017

J W Pape

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 November 2017

1 reference

30 November 2017

356

1 reference

30 November 2017

9240

1 reference

30 November 2017

1470-1474

1 reference

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with Human Immunodeficiency Virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Infectious Diseases Society of American

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

American Thoracic Society. Diagnostic standards and classification of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

A rapid manual method for CD4+ T-cell quantitation for use in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Directly observed therapy and treatment adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902870-1

7 January 2021

10.1016/S0140-6736(00)02870-1

Identifiers

DOI

1 reference

30 November 2017

1 reference